Artificial intelligence is rapidly transforming healthcare, moving beyond experimentation and delivering a measurable return on investment, according to a new report. A recent survey by NVIDIA revealed that 70% of healthcare organizations are now actively using AI, a significant increase from 63% in 2024. This surge in adoption is fueled by advancements in areas like medical imaging, drug discovery, and administrative streamlining, promising to reshape how care is delivered and research is conducted.
The “State of AI in Healthcare and Life Sciences: 2026 Trends” report highlights a growing confidence in AI’s ability to improve both clinical and operational outcomes. Notably, 69% of organizations are now leveraging generative AI and large language models, up from 54% the previous year. This shift indicates a broader acceptance of AI’s potential to analyze complex data, accelerate research, and personalize patient care. The increasing use of AI isn’t limited to specific sectors within healthcare; adoption is rising across the board, from digital health companies to pharmaceutical giants and traditional hospitals.
The financial implications of this AI integration are becoming increasingly clear. A substantial 85% of executives surveyed reported that AI is helping to increase revenue, while 80% noted a reduction in costs. These gains are being realized through a variety of applications, including improved diagnostic accuracy, faster drug development cycles, and more efficient administrative processes. John Nosta, president of NostaLab, a healthcare reckon tank, suggests that the most immediate impact will be seen in areas like scheduling, documentation, and care coordination, where AI can automate tasks and free up healthcare professionals to focus on patient interaction.
One key driver of this growth is the increasing embrace of open-source AI models and software. According to the NVIDIA report, 82% of respondents consider open-source solutions to be moderately to extremely crucial to their AI strategy. This trend allows organizations to customize AI applications to their specific needs, fostering innovation and accelerating development. Yet, the report also acknowledges the continued need for proprietary systems in clinical settings where safety, liability, and accountability are paramount.
AI Adoption Across the Healthcare Landscape
The adoption of AI isn’t uniform across the healthcare spectrum. Digital healthcare organizations lead the way, with 78% actively using AI, followed closely by medical technology companies at 74%. Payers and providers, traditionally slower to adopt new technologies, have also seen a significant increase in AI use, rising from 43% to 56% year-over-year. This broad-based adoption suggests that AI is becoming an integral part of the healthcare ecosystem.
The most common AI workloads currently being deployed include generative AI and large language models, followed by AI for data analytics and data science, and predictive analytics. A newer area of focus, “agentic AI” – which uses AI agents to automate knowledge retrieval and research – is gaining traction, with 47% of respondents currently using or assessing its potential. Specific use cases vary by sector. For example, 61% of medical technology companies are utilizing AI for medical imaging, while 57% of pharmaceutical and biotechnology firms are applying it to drug discovery.
Return on Investment: Where AI is Delivering Value
The financial benefits of AI in healthcare are becoming increasingly tangible. The NVIDIA report found that 57% of medical technology companies are seeing a return on investment from AI-powered medical imaging, while 46% of pharmaceutical and biotechnology firms are realizing gains from AI-driven drug discovery and development. For digital healthcare providers, virtual health assistants and chatbots are proving to be a valuable ROI driver, cited by 37% of respondents. Payers and providers are finding success in administrative tasks and workflow optimization, with 39% reporting positive returns in these areas.
As a result of these positive outcomes, investment in AI is expected to continue growing. A significant 85% of respondents indicated plans to increase their AI budgets this year, with 46% anticipating a significant increase of more than 10%. Dr. Annabelle Painter, clinical AI strategy lead at Visiba U.K., emphasizes the importance of prioritizing evaluation alongside implementation, ensuring that AI delivers measurable improvements in patient safety, quality, and care.
The Role of Open Source and Future Outlook
The growing importance of open-source software in AI development is also noteworthy. With 82% of survey respondents considering it moderately to extremely important, open-source models are fostering innovation and allowing organizations to build customized solutions. However, the report stresses that while open-source models are valuable for exploration, proprietary systems remain essential for validation, integration, and trust in clinical environments where safety and accountability are critical.
The healthcare industry’s embrace of AI is poised to accelerate in the coming years. As AI technologies mature and develop into more integrated into existing workflows, One can expect to see even greater improvements in patient care, research efficiency, and operational effectiveness. The next step, according to NVIDIA, is to further adapt AI across science, robotics, and intelligent agents, continuing to drive innovation and improve outcomes for patients and providers alike.
Disclaimer: This article provides information about healthcare technology and should not be considered medical advice. Consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What impact do you foresee AI having on your healthcare experience? Share your thoughts in the comments below.
